Image credit: Alyson Martin

FDA Says Agency Is Working on “Flexibilities” It Might Have on Cannabis

FDA Principal Deputy Commissioner Janet Woodcock called cannabis scheduling review a “very high priority” during an event hosted by the Council for Federal Cannabis Regulation.

United States
Congress, Newsletter

Outgoing Rep. Blumenauer Talks Banking, Hemp, and Trump

An excerpt from the Cannabis Wire Daily newsletter.

Newsletter, Regulation

Who’s Calling for a Hearing on Rescheduling?

An excerpt from the Cannabis Wire Daily newsletter.